Berto P, Bellone M, Sabinot A, et al. Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 2022;23(1). https://doi.org/10.7175/fe.v23i1.1516